Latha Vairavan - Vice President, Finance & Investor Relations
Frank Watanabe - President & Chief Executive Officer
Todd Edwards - Chief Commercial Officer
Patrick Burnett - Chief Medical Officer
David Topper - Chief Financial Officer
Good day and welcome to Arcutis Biotherapeutics 2024 Fourth Quarter and Full Year Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I will now hand the call over to Latha Vairavan, Vice President of Finance and Corporate Controller. Please go ahead.
Latha Vairavan
Thank you. Good afternoon, everyone and thank you for joining us today to review our fourth quarter and full year 2024 financial results and business updates. Slides for today's call are available on the Investor section of the Arcutis website. On the call today are Frank Watanabe, President and CEO; Patrick Burnett, Chief Medical Officer; Todd Edwards, Chief Commercial Officer; and David Topper, Chief Financial Officer.
I would like to remind everyone that we will be making forward-looking statements during this call. These statements are subject to certain risks and uncertainties and our actual results may differ. We encourage you to review all of the company's filings with the Securities and Exchange Commission including descriptions of our business and risk factors.